PRMT5 is a therapeutic target in choroidal neovascularization

Ocular neovascular diseases including neovascular age-related macular degeneration (nvAMD) are widespread causes of blindness. Patients’ non-responsiveness to currently used biologics that target vascular endothelial growth factor (VEGF) poses an unmet need for novel therapies. Here, we identify pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Muniyandi, Anbukkarasi, Martin, Matthew, Sishtla, Kamakshi, Motolani, Aishat, Sun, Mengyao, Jensen, Nathan R., Qi, Xiaoping, Boulton, Michael E., Prabhu, Lakshmi, Lu, Tao, Corson, Timothy W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889383/
https://www.ncbi.nlm.nih.gov/pubmed/36720900
http://dx.doi.org/10.1038/s41598-023-28215-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889383/
https://www.ncbi.nlm.nih.gov/pubmed/36720900
http://dx.doi.org/10.1038/s41598-023-28215-w

Ejemplares similares